Date & Time : 5 October 2026 | 17:00-18:00 CEST | Online
.png.aspx?width=600&height=502)
In this opening webinar, leading centres share why transitioning to RTT-only adaptive radiotherapy became a necessary step. What factors drove the shift? How was responsibility structured and what has proven sustainable? This session draws practical lessons from real-world experience. It serves as a warm-up to the rest of the series.
Chairs
- Meegan Shepherd, RTT, Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW, Australia; University of Sydney; Monash University, Clayton, VIC, Australia – Chair
- Dylan Callens, RTT, UZ Leuven and KU Leuven, Leuven, Belgium — Chair
Speakers
- Karin Goudschaal, RTT, Amsterdam UMC, Amsterdam, the Netherlands and Cancer Center Amsterdam, Cancer Therapy, Amsterdam, The Netherlands.
- Shabanaz Boodhoo, RTT, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
- Roel Bouwmans, RTT, UMC Utrecht, Utrecht,The Netherlands
Programme
17:00 – 07:05 | Introduction by Chairs — 5 min
07:05 – 17:20 | Talk 1: Karin Goudschaal: Building a Sustainable RTT-Led Service: CBCT-Guided oART for Bladder Cancer — 12 + 3 min QA
17:20 – 17:35 | Talk 2: Shabanaz Boodhoo: Implementing the Radixact System with an RTT/Dosimetrist-Led oART Service — 12 + 3 min QA
17:35 – 17:50 | Talk 3: Roel Bouwmans: From Multidisciplinary to RTT-only: Online Adaptive MR-Guided Radiotherapy at Scale and Beyond with Evo — 12 + 3 min QA
17:50 – 18:00 | Plenary QA session
Learning Objectives
By the end of this webinar, participants should be able to:
-Learn the clinical and workforce drivers that led centres to adopt RTT-only ART models. (the why)
-Learn how responsibility and accountability were structured within these implementations. (the how)
-Learn success factors and sustainability considerations from early adopters. (the evaluation)
-Learn about the readiness of participants’ own centre to move toward RTT-only adaptive practice. (the experience)
-Learn the implementation themes that will be explored in greater depth throughout the webinar series. (the challenges)
Resources
Goudschaal, K., Azzarouali, S., Visser, J., Admiraal, M., Wiersma, J., van Wieringen, N., de la Fuente, A., Piet, M., Daniels, L., den Boer, D., Hulshof, M., & Bel, A. (2024). Clinical implementation of RTT-only CBCT-guided online adaptive focal radiotherapy for bladder cancer. Clinical and translational radiation oncology, 50, 100884. https://doi.org/10.1016/j.ctro.2024.100884
de Jong, R., Visser, J., van Wieringen, N., Wiersma, J., Geijsen, D., & Bel, A. (2021). Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer. Radiation oncology (London, England), 16(1), 136. https://doi.org/10.1186/s13014-021-01866-7